Arnett, Simon http://orcid.org/0000-0003-4582-1171
Chew, Sin Hong http://orcid.org/0000-0002-4697-5415
Leitner, Unnah http://orcid.org/0000-0001-8914-9941
Hor, Jyh Yung http://orcid.org/0000-0003-2244-879X
Paul, Friedemann http://orcid.org/0000-0002-6378-0070
Yeaman, Michael R. http://orcid.org/0000-0002-9468-5252
Levy, Michael http://orcid.org/0000-0002-7969-8346
Weinshenker, Brian G. http://orcid.org/0000-0001-5806-6203
Banwell, Brenda L. http://orcid.org/0000-0001-6354-6770
Fujihara, Kazuo http://orcid.org/0000-0002-3096-4156
Abboud, Hesham http://orcid.org/0000-0001-5346-8254
Dujmovic Basuroski, Irena http://orcid.org/0000-0002-5179-1901
Arrambide, Georgina http://orcid.org/0000-0002-2657-5510
Neubrand, Veronika E. http://orcid.org/0000-0002-3793-8487
Quan, Chao http://orcid.org/0000-0003-1040-3930
Melamed, Esther http://orcid.org/0000-0001-5571-3591
Palace, Jacqueline http://orcid.org/0000-0003-4779-6133
Sun, Jing http://orcid.org/0000-0002-0097-2438
Asgari, Nasrin http://orcid.org/0000-0001-8551-0947
Broadley, Simon A. http://orcid.org/0000-0002-9429-4307
,
Abboud, Hesham
Aktas, Orhan
Alroughani, Raed
Altintas, Ayse
Apiwattannakul, Metha
Arrambide, Georgina
Avasarala, Jagannadha
Banwell, Brenda
Blaschke, Terrence F.
Bowen, James
Contentti, Edgar Carnero
Chitnis, Tanuja
de Seze, Jerome
Delgado-Garcia, Guillermo
Dujmovic Basuroski, Irena
Flores, Jose
Fujihara, Kazuo
Galleguillos, Lorna
Greenberg, Benjamin M.
Han, May
Havla, Joachim
Hellwig, Kerstin
Hor, Jyh Yung
Jarius, Sven
Jimenez, Jorge Andres
Kissani, Najib
Kleiter, Ingo
Lana-Peixoto, Marco
Leite, M. Isabel
Levy, Michael
Mariotto, Sara
Mealy, Maureen A.
Neubrand, Veronika E.
Oreja-Guevara, Celia
Pandit, Lekha
Planchon, Sarah M.
Pröbstel, Anne-Katrin
Qian, Peiqing
Quan, Chao
Repovic, Pavle
Riley, Claire
Ringelstein, Marius
I.Rojas, Juan
Rotstein, Dalia
Ruprecht, Klemens
Sá, Maria José
Saiz, Albert
Salama, Sara
Siritho, Sasitorn
Siva, Aksel
Smith, Terry J.
Sotirchos, Elias S.
de Castillo, Ibis Soto
Tenembaum, Silvia
Villoslada, Pablo
Willekens, Barbara
Wingerchuk, Dean
Yamout, Bassem I.
Yeaman, Michael
Funding for this research was provided by:
Griffith University
Article History
Received: 14 March 2024
Revised: 15 May 2024
Accepted: 16 May 2024
First Online: 3 July 2024
Declarations
:
: SA, SHC, UL, JYH, GA, VEN, JQ, EM, JS and NA declare no conflicts of interest. FP has received research support from DFG, BMBF, KKNMS, and the Guthy-Jackson Charitable Foundation. He serves on steering committees of the OCTIMS study (Novartis) and the N-Momentum study (Viela Bio) and has received personal compensation and research support from Alexion, Bayer, Biogen, Roche, Merck, Teva, Shire, Celgene, Novartis, and Sanofi Genzyme. He is an associate editor of Neurology: Neuroimmunology and Neuroinflammation. MRY is the founder of NovaDigm Therapeutics, Inc, and Metacin, Inc. He is a member of the Genentech Scientific Advisory Committee and has received travel expenses or honoraria from Genentech and Alexion. ML has had roles as a pharmaceutical consultant for Alexion, Chugai, Horizon, Roche, Genzyme, UCB, and Quest Diagnostics, and has received grants from Alexion, Shire, Horizon, Genzyme, Sanofi, UCB. BGW has received royalties from RSR Ltd, Oxford University, Hospices Civil de Lyon, and MVZ Labor PD Dr. Volkmann und Kollegen GbR for a patent of NMO-IgG as a diagnostic test for NMO and related disorders, served on adjudication committee for clinical trials in NMO being conducted by MedImmune and Alexion, and consulted for Chugai, Mitsubishi-Tanabe regarding a clinical trial for NMO. BLB has received personal fees from Novartis. KF has received grants from Ministry of Education, Science and Technology of Japan and the Ministry of Health, Welfare, and Labor of Japan, and received honoraria, and/or travel expenses for speaking, and/or advisory boards from Mitsubishi Tanabe, Biogen, Bayer, Takeda, Novartis, Alexion, VielaBio, Asahi Kasei, Dainihon Sumitomo, Eisai, Teijin, Ono, Roche, and Chugai. H. Abboud has received consultancy and speaker fees from Biogen, Genentech-Roche, Bristol Myers Squibb, Alexion, and Horizon, and has received research support from Genentech-Roche, Novartis, Sanofi-Genzyme, and Bristol Myers Squibb to conduct clinical trials. IDB has been a site Principal Investigator in clinical trials and projects sponsored by Alexion Pharmaceuticals/Astra Zeneca and CorEvitas, has received travel reimbursement from The Guthy-Jackson Charitable Foundation, is a member of The Guthy-Jackson Charitable Foundation International Clinical Consortium; and received grant support from The Bodford Family Transverse Myelitis Center Research Fund. JP has received support for scientific meetings and honorariums for advisory work from Merck-Serono, Sandoz, Sanofi, Novartis, Chugai, Alexion, Clene, Roche, Medimmune, Amgen, Vitaccess, UCB, Mitsubishi, Amplo and Janssen. Grants from Alexion, Argenx, Roche, Medimmune, UCB and Amplo biotechnology. Patent ref P37347WO and license agreement Numares multimarker MS diagnostics. Has shares in AstraZenica. SAB has received honoraria for attendance at advisory boards and travel sponsorship from Biogen-Idec, Merck-Serono, Novartis and Sanofi-Genzyme; has received speakers honoraria from Biogen-Idec and Genzyme; is an investigator in clinical trials sponsored by Biogen Idec and Novartis.